Return to Purdey Home Page Last updated 26/8/04

Page 2. References : Parkinsons, Carbon disulphide, cancer, mobile phones, Radon, autism and ADHD, ulcerative colitis, HIV, Migraine, Rheumatoid arthritis, Chinese herbs/allergy and pollution, Motor Neurone Disease, Alzheimer's, ALS and neurodegenerative disease, Guam diseases, Systemic Lupus, schizophrenia, homeopathy, Sudden infant death syndrome, Fluoride

Parkinson's disease

Nash JE, Brotchie JM. Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.
Mov Disord. 2002 May;17(3):455-66.

Sieradzan KA, Fox SH, Hill M, Dick JP, Crossman AR, Brotchie JM. Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology. 2001 Dec 11;57(11):2108-11.

Hille CJ, Fox SH, Maneuf YP, Crossman AR, Brotchie JM. Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease. Exp Neurol. 2001 Nov;172(1):189-98.
Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci. 2001 Aug;2(8):577-88. Review.
Birkmayer W, Birkmayer GJ. Nicotinamidadenindinucleotide (NADH): the new approach in the therapy of Parkinson's disease. Ann Clin Lab Sci. 1989 Jan-Feb;19(1):38-43.

Birkmayer GJ, Birkmayer W. Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH). Acta Neurol Scand Suppl. 1989;126:183-7.

Birkmayer W, Birkmayer GJ, Vrecko K, Mlekusch W, Paletta B, Ott E. The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patients. J Neural Transm Park Dis Dement Sect. 1989;1(4):297-302.

Parkinson's and vitamins - National Parkinson Foundation , good general site.

Checkoway H, Farin FM, Costa-Mallen P, Kirchner SC, Costa LG. Genetic polymorphisms in Parkinson's disease. Neurotoxicology. 1998 Aug-Oct;19(4-5):635-43. Review.

Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. The herbicide paraquat causes upregulation and aggregation of alpha-synuclein in mice. J Biol Chem. 2001 Nov 13 [epub ahead of print]

Parsons RB, Waring RH, Ramsden DB, Williams AC. In vitro effect of the cysteine metabolites homocysteic acid, homocysteine and cysteic acid upon human neuronal cell lines. Neurotoxicology. 1998 Aug-Oct;19(4-5):599-603.

Grimes JD, Hassan MN, Thakar JH. Prevention of progression of Parkinson's disease with antioxidative therapy.
Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(2-3):165-72. Review.

Lee HJ, Choi C, Lee SJ. Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of cytosolic form.
J Biol Chem. 2001 Oct 25 [epub ahead of print]

Berg D, Gerlach M, Youdim MB, Double KL, Zecca L, Riederer P, Becker G. Brain iron pathways and their relevance to Parkinson's disease.
J Neurochem. 2001 Oct;79(2):225-36.

Sharma N, McLean PJ, Kawamata H, Irizarry MC, Hyman BT. Alpha-synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies. Acta Neuropathol (Berl). 2001 Oct;102(4):329-34.

Ramsden DB, Parsons RB, Ho SL, Xie T, Waring RH, Williams AC. Further studies in xenobiotic metabolism and Parkinson's disease.
Adv Neurol. 2001;86:105-13. No abstract available

Uversky VN, Li J, Fink AL. Metal-triggered structural transformations, aggregation and fibrillation of human alpha-synuclein. A possible molecular link between parkinson's disease and heavy metal exposure. J Biol Chem. 2001 Sep 11 [epub ahead of print]

Steventon GB, Sturman S, Waring RH, Williams AC.
Areview of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease.
Drug Metabol Drug Interact. 2001;18(2):79-98. Review.

Williams AC, Smith ML, Waring RH, Ramsden DB.
Idiopathic Parkinson's disease: a genetic and environmental model. Adv Neurol. 1999;80:215-8. Review. No abstract available.

Ho SL, McCann KP, Bennett P, Kapadi AL, Waring RH, Ramsden DB, Williams AC.
The molecular biology of xenobiotic enzymes and the predisposition to idiopathic Parkinson's disease. Adv Neurol. 1996;69:53-60. Review. No abstract available.

Sherer TB, Betarbet R, Greenamyre JT. Pathogenesis of Parkinson's disease. Curr Opin Investig Drugs. 2001 May;2(5):657-62. Review.

Uversky VN, Li J, Fink AL. Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease. FEBS Lett. 2001 Jul 6;500(3):105-8.

Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental risk factors and Parkinson's disease: a metaanalysis.
Environ Res. 2001 Jun;86(2):122-7.

Woodward G. Autism and Parkinson's disease. Med Hypotheses. 2001 Feb;56(2):246-9.

Herishanu YO, Medvedovski M, Goldsmith JR, Kordysh E. A case-control study of Parkinson's disease in urban population of southern Israel. Can J Neurol Sci. 2001 May;28(2):144-7.

Williams A, Waring R. The MPTP tale: pathway to prevention of Parkinson's disease? Br J Hosp Med. 1993 May 19-Jun 1;49(10):716-9. Review.
Williams AC, Pall HS, Steventon GB, Green S, Buttrum S, Molloy H, Waring RH. N-methylation of pyridines and Parkinson's disease.Adv Neurol. 1993;60:194-6. No abstract available.

Green S, Buttrum S, Molloy H, Steventon G, Sturman S, Waring R, Pall H, Williams A. N-methylation of pyridines in Parkinson's disease. Lancet. 1991 Jul 13;338(8759):120-1. No abstract available

Williams A, Steventon G, Sturman S, Waring R. Xenobiotic enzyme profiles and Parkinson's disease.
Neurology. 1991 May;41(5 Suppl 2):29-32; discussion 32-3.

Humfrey CD, Steventon GB, Sturman SG, Waring RH, Griffiths B, Williams AC. Monoamine oxidase substrates in Parkinson's disease. Biochem Pharmacol. 1990 Dec 1;40(11):2562-4. No abstract available.

Steventon G, Humfrey C, Sturman S, Waring RH, Williams AC. Monoamine oxidase B and Parkinson's disease.
Lancet. 1990 Jan 20;335(8682):180. No abstract available

Steventon GB, Heafield MT, Waring RH, Williams AC Xenobiotic metabolism in Parkinson's disease.
Neurology. 1989 Jul;39(7):883-7.

Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson's disease.
J Neurol Neurosurg Psychiatry. 1997 May;62(5):436-46.

Zhang J, Kravtsov V, Amarnath V, Picklo MJ, Graham DG, Montine TJ. Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease. J Neurochem. 2000 Mar;74(3):970-8.

Menon MK, Clark WG, Aures D. The central stimulant and potential antiparkinsonism effects of 2(p-nitrobenzylthio)-imidazoline (3H)-HCl. Eur J Pharmacol. 1972 Jul;19(1):43-51. No abstract available.

Grundig E, Gerstenbrand F, Oberhummer J, Simanyi M, Schedl R, Weiss J. [Biochemical aspects of the effect of L-dopa in patients with Parkinson's disease]. Z Neurol. 1972;203(1):73-90. German. No abstract available.

Grundig E, Gerstenbrand F. [Correlation between Parkinsonism symptoms and a disorder in the amino acid metabolism in CNS]. Wien Klin Wochenschr. 1970 Nov 6;82(45):811-6. German. No abstract available.

Morris HR, Al-Sarraj S, Schwab C, Gwinn-Hardy K, Perez-Tur J, Wood NW, Hardy J, Lees AJ, McGeer PL, Daniel SE, Steele JC. A clinical and pathological study of motor neurone disease on Guam. Brain. 2001 Nov;124(Pt 11):2215-22.
Paxinou E, Chen Q, Weisse M, Giasson BI, Norris EH, Rueter SM, Trojanowski JQ, Lee VM, Ischiropoulos H. Induction of alpha-synuclein aggregation by intracellular nitrative insult. J Neurosci. 2001 Oct 15;21(20):8053-61.

Przedborski S, Chen Q, Vila M, Giasson BI, Djaldatti R, Vukosavic S, Souza JM, Jackson-Lewis V V, Lee VM, Ischiropoulos H. Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J Neurochem. 2001 Jan;76(2):637-640.

Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, Stern MB, Gollomp SM, Ischiropoulos H, Lee VM, Trojanowski JQ. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol. 2000 Nov;157(5):1439-45.

Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000 Nov 3;290(5493):985-9.

Souza JM, Giasson BI, Chen Q, Lee VM, Ischiropoulos H. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem. 2000 Jun 16;275(24):18344-9

Paxinou E, Chen Q, Weisse M, Giasson BI, Norris EH, Rueter SM, Trojanowski JQ, Lee VM, Ischiropoulos H. Induction of alpha-synuclein aggregation by intracellular nitrative insult. J Neurosci. 2001 Oct 15;21(20):8053-61.

Przedborski S, Chen Q, Vila M, Giasson BI, Djaldatti R, Vukosavic S, Souza JM, Jackson-Lewis V V, Lee VM, Ischiropoulos H. Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J Neurochem. 2001 Jan;76(2):637-640.

Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, Stern MB, Gollomp SM, Ischiropoulos H, Lee VM, Trojanowski JQ. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol. 2000 Nov;157(5):1439-45.

Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000 Nov 3;290(5493):985-9.
Souza JM, Giasson BI, Chen Q, Lee VM, Ischiropoulos H. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.
J Biol Chem. 2000 Jun 16;275(24):18344-9.

Carbon disulphide and disease

Torres M, Jarvisalo J, Hakim J. Effect of carbon disulfide on superoxide anion production by rat liver microsomes.
Exp Mol Pathol. 1981 Jun;34(3):331-7. No abstract available.
Torres M, Jarvisalo J, Feldmann G, Hakim J. Superoxide anion: its involvement in carbon disulfide hepatotoxicity in phenobarbital-treated rats. Bull Eur Physiopathol Respir. 1981;17 Suppl:237-45. No abstract available.
Kapoor S, Priyadarsini KI. Protection of radiation-induced protein damage by curcumin.
Biophys Chem. 2001 Aug 30;92(1-2):119-26.
Sills RC, Valentine WM, Moser V, Graham DG, Morgan DL. Characterization of carbon disulfide neurotoxicity in C57BL6 mice: behavioral, morphologic, and molecular effects. Toxicol Pathol. 2000 Jan-Feb;28(1):142-8.

Cohen G, Kesler N. Monoamine oxidase and mitochondrial respiration. J Neurochem. 1999 Dec;73(6):2310-5.

Kane FJ Jr. Carbon disulfide intoxication from overdosage of disulfiram. Am J Psychiatry. 1970 Nov;127(5):690-4. No abstract available.

Nie Y, Zhang J, Xi S, Yang Z. [Emissions of biogenic sulfur gases from wheat fields].
Huan Jing Ke Xue. 2001 Jul;22(4):25-8. Chinese.

Jian L, Chiang H. Influence of carbon disulphide on hydroxyl radicals in the phenanthroline chemiluminescence system.
Luminescence. 2001 Jul-Aug;16(4):291-3.

Jian L. Increased carbon disulfide-stimulated chemiluminescence in the pyrogallol-luminol system.
Luminescence. 2001 Jul-Aug;16(4):281-3.

McKee ML, Wine PH. Ab initio study of the atmospheric oxidation of CS2.
J Am Chem Soc. 2001 Mar 14;123(10):2344-53.

Wang L, Zhang F, Chen J. Carbonyl sulfide derived from catalytic oxidation of carbon disulfide over atmospheric particles.
Environ Sci Technol. 2001 Jun 15;35(12):2543-7.

Bortkiewicz A, Gadzicka E, Szymczak W. Cardiovascular disturbances in workers exposed to carbon disulfide.
Appl Occup Environ Hyg. 2001 Apr;16(4):455-63.

Kotseva K, Braeckman L, De Bacquer D, Bulat P, Vanhoorne M. Cardiovascular effects in viscose rayon workers exposed to carbon disulfide. Int J Occup Environ Health. 2001 Jan-Mar;7(1):7-13.

Delcourt J, Sandino JP. Performance assessment of a passive sampler in industrial atmospheres.
Int Arch Occup Environ Health. 2001 Jan;74(1):49-54.

Kotseva K. Occupational exposure to low concentrations of carbon disulfide as a risk factor for hypercholesterolaemia.
Int Arch Occup Environ Health. 2001 Jan;74(1):38-42.

Gobba F. Color vision: a sensitive indicator of exposure to neurotoxins.
Neurotoxicology. 2000 Oct;21(5):857-62. Review.

Sinczuk-Walczak H. [Diagnostic neurologic procedures and certification in persons chronically exposed to carbon disulfide in light of personal cases]. Med Pr. 2000;51(4):345-9. Polish.

Jian L, Hu D. Antioxidative stress response in workers exposed to carbon disulfide.
Int Arch Occup Environ Health. 2000 Sep;73(7):503-6.

Tonkin EG, Erve JC, Valentine WM. Disulfiram produces a non-carbon disulfide-dependent schwannopathy in the rat.
J Neuropathol Exp Neurol. 2000 Sep;59(9):786-97

Candura SM, Butera R, Gandini C, Locatelli C, Tagliani M, Fasola D, Manzo L. [Occupational poisoning with psychiatric manifestations]. G Ital Med Lav Ergon. 2000 Jan-Mar;22(1):52-61; discussion 62-3. Review. Italian.

Ghittori S, Abatangelo L, Imbriani M. [Biologic monitoring of carbon disulfide: role of glutathione].
G Ital Med Lav Ergon. 1999 Oct-Dec;21(4):341-6. Review. Italian.

Mihalache C, Mihalache G, Mihalache LI, Indrei A. [Experimental carbon disulfide-induced encephalopathy].
Rev Med Chir Soc Med Nat Iasi. 1997 Jul-Dec;101(3-4):91-4. Romanian.

Graham DG. Carbon disulfide. Environ Health Perspect. 2000 Mar;108(3):A110-2. No abstract available

Jiang B, Zhang S, Huang J, Lu J .[Study on electroneuromyography of 175 workers exposed to carbon disulfide]. Wei Sheng Yan Jiu. 1998 Mar;27(2):84-6. Chinese.

Cancer

Frankenberg D, Frankenberg-Schwager M, Garg I, Pralle E, Uthe D, Greve B, Severin E, Gohde W. Mutation induction and neoplastic transformation in human and human-hamster hybrid cells: dependence on photon energy and modulation in the low-dose range. J Radiol Prot. 2002 Sep;22(3A):A17-20.
Frankenberg D, Kelnhofer K, Garg I, Bar K, Frankenberg-Schwager M. Enhanced mutation and neoplastic transformation in human cells by 29 kVp relative to 200 kVp X rays indicating a strong dependence of RBE on photon energy. Radiat Prot Dosimetry. 2002;99(1-4):261-4.
Slade N, Storga-Tomic D, Birkmayer GD, Pavelic K, Pavelic J. Effect of extracellular NADH on human tumor cell proliferation. Anticancer Res. 1999 Nov-Dec;19(6B):5355-60.
Weber T, Lu M, Andera L, Lahm H, Gellert N, Fariss MW, Korinek V, Sattler W, Ucker DS, Terman A, Schroder A, Erl W, Brunk UT, Coffey RJ, Weber C, Neuzil J. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
Clin Cancer Res. 2002 Mar;8(3):863-9.
Foukas LC, Daniele N, Ktori C, Anderson KE, Jensen J, Shepherd PR.Direct effects of caffeine and theophylline on the p110d and other phosphoinositiode 3-kinases; Differential effects on lipid kinase and protein kinase activities.
J Biol Chem. 2002 Jul 26 [epub ahead of print]
Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, Seow A, Lee HP, Yu MC. Mammographic Parenchymal Patterns and Self-reported Soy Intake in Singapore Chinese Women. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):608-13.
Nagata C, Takatsuka N, Kawakami N, Shimizu H. A prospective cohort study of soy product intake and stomach cancer death. Br J Cancer. 2002 Jul 1;87(1):31-6.
Shu XO, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, Ruan Z, Gao YT, Zheng W. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):483-8.
Joseph MG, Banerjee D, Kocha W, Feld R, Stitt LW, Cherian MG. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
Cancer. 2001 Aug 15;92(4):836-42.
Avizienyte E, Wyke AW, Jones RJ, McLean GW, Westhoff MA, Brunton VG, Frame MC. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol. 2002 Aug;4(8):632-8.
Frame MC. Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta. 2002 Jun 21;1602(2):114-30.
Frame MC, Fincham VJ, Carragher NO, Wyke JA. v-Src's hold over actin and cell adhesions. Nat Rev Mol Cell Biol. 2002 Apr;3(4):233-45. Review.
Kimoto E, Tanaka H, Gyotoku J, Morishige F, Pauling L. Enhancement of antitumor activity of ascorbate against Ehrlich ascites tumor cells by the copper:glycylglycylhistidine complex. Cancer Res. 1983 Feb;43(2):824-8.
Dunham WB, Zuckerkandl E, Reynolds R, Willoughby R, Marcuson R, Barth R, Pauling L. Effects of intake of L-ascorbic acid on the incidence of dermal neoplasms induced in mice by ultraviolet light. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7532-6.
Villeneuve PJ, Agnew DA, Johnson KC, Mao Y. Brain cancer and occupational exposure to magnetic fields among men: results from a Canadian population-based case-control study. Int J Epidemiol. 2002 Feb;31(1):210-217.

The OP Dichlorvos and cancer

Anti cancer and polyphenolic anti oxidants /quercertin etc
New Scientist :Carpets, curtains and crcinogens:
Savitz DA, Calle EE. Leukemia and occupational exposure to electromagnetic fields: review of epidemiologic surveys. J Occup Med. 1987 Jan;29(1):47-51. Review.
Journal of Cancer prevention: http://www.cancerprev.org/
Baxter G J, Graham A B, Lawrence J R, Wiles D, Paterson J R. Salicylic acid in soups prepared from organically and non-organically grown vegetables. Eur J Nutr. 2001 Dec;40(6):289-92.
Blacklock CJ, Lawrence JR, Wiles D, Malcolm EA, Gibson IH, Kelly CJ, Paterson JR Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin. J Clin Pathol. 2001 Jul;54(7):553-5.
Paterson JR, Lawrence JR. Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer. QJM. 2001 Aug;94(8):445-8. Review.
Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC. Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population. Lung Cancer. 2001 Nov;34(2):177-83.
Cherry N, Labreche F, Collins J, Tulandi T. Occupational exposure to solvents and male infertility.
Occup Environ Med. 2001 Oct;58(10):635-40.
Meyer JD, Holt DL, Chen Y, Cherry NM, McDonald JC. SWORD '99: surveillance of work-related and occupational respiratory disease in the UK. Occup Med (Lond). 2001 May;51(3):204-8.
Macfarlane GJ, Thomas E, Cherry N. Mortality among UK Gulf War veterans. Lancet. 2000 Jul 1;356(9223):17-21.
Cherry N. Re: "Cancer incidence near radio and television transmitters in Great Britain. . Sutton Coldfield transmitter; II. All high power transmitters". Am J Epidemiol. 2001 Jan 15;153(2):204-5. No abstract available.
Kirk CJ, Harris RM, Wood DM, Waring RH, Hughes PJ.
Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens? Biochem Soc Trans. 2001 May;29(Pt 2):209-16.
Harris RM, Hawker RJ, Langman MJ, Singh S, Waring RH.
Inhibition of phenolsulphotransferase by salicylic acid: a possible mechanism by which aspirin may reduce carcinogenesis.
Gut. 1998 Feb;42(2):272-5
Bounous G. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment.
Anticancer Res. 2000 Nov-Dec;20(6C):4785-92. Review.
Kennedy RS, Konok GP, Bounous G, Baruchel S, Lee TD. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical study. Anticancer Res. 1995 Nov-Dec;15(6B):2643-9.

 

French PW, Penny R, Laurence JA, McKenzie DR. Mobile phones, heat shock proteins and cancer.
Differentiation. 2001 Jun;67(4-5):93-7.
Cramer DW, Kuper H, Harlow BL, Titus-Ernstoff L. Carotenoids, antioxidants and ovarian cancer risk in pre- and postmenopausal women. Int J Cancer. 2001 Oct 1;94(1):128-34.
Okabe S, Suganuma M, Imayoshi Y, Taniguchi S, Yoshida T, Fujiki H New TNF-alpha releasing inhibitors, geraniin and corilagin, in leaves of Acer nikoense, Megusurino-ki. Biol Pharm Bull. 2001 Oct;24(10):1145-8.
Salganik RI.The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population.
J Am Coll Nutr. 2001 Oct;20(5 Suppl):464S-472S; discussion 473S-475S.

Prasad KN, Cole WC, Kumar B, Prasad KC Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies. J Am Coll Nutr. 2001 Oct;20(5 Suppl):450S-463S; discussion 473S-475S.
Combs GF Jr, Clark LC, Turnbull BW. An analysis of cancer prevention by selenium. Biofactors. 2001;14(1-4):153-9. Review.
Finley JW, Davis CD. Selenium (Se) from high-selenium broccoli is utilized differently than selenite, selenate and selenomethionine, but is more effective in inhibiting colon carcinogenesis. Biofactors. 2001;14(1-4):191-6.
Barber R, Delahunt B, Grebe SK, Davis PF, Thornton A, Slim GC. Oral shark cartilage does not abolish carcinogenesis but delays tumor progression in a murine model. Anticancer Res. 2001 Mar-Apr;21(2A):1065-9.
Kim JT, Kim MS, Bae MK, Song HS, Ahn MY, Kim YJ, Lee SJ, Kim KW. Cloning and characterization of tissue inhibitor of metalloproteinase-3 (TIMP-3) from shark, Scyliorhinus torazame. Biochim Biophys Acta. 2001 Jan 26;1517(2):311-5.
Gonzalez RP, Soares FS, Farias RF, Pessoa C, Leyva A, de Barros Viana GS, Moraes MO. Demonstration of inhibitory effect of oral shark cartilage on basic fibroblast growth factor-induced angiogenesis in the rabbit cornea. Biol Pharm Bull. 2001 Feb;24(2):151-4.
Ricciarelli R, Zingg JM, Azzi A .Vitamin E: protective role of a Janus molecule. FASEB J. 2001 Nov;15(13):2314-25
McDuffie HH, Pahwa P, McLaughlin JR, Spinelli JJ, Fincham S, Dosman JA, Robson D, Skinnider LF, Choi NW. Non-Hodgkin's Lymphoma and Specific Pesticide Exposures in Men: Cross-Canada Study of Pesticides and Health. Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1155-63.
Tisch M, Lohmeier A, Schmezer P, Bartsch H, Maier H. [Genotoxic effect of the insecticides pentachlorophenol and lindane on human nasal mucosal epithelium].
Dtsch Med Wochenschr. 2001 Jul 27;126(30):840-4. German.
Revich B, Aksel E, Ushakova T, Ivanova I, Zhuchenko N, Klyuev N, Brodsky B, Sotskov Y. Dioxin exposure and public health in Chapaevsk, Russia. Chemosphere. 2001 May-Jun;43(4-7):951-66.
Klein RG, Schmezer P, Amelung F, Schroeder HG, Woeste W, Wolf J. Carcinogenicity assays of wood dust and wood additives in rats exposed by long-term inhalation. Int Arch Occup Environ Health. 2001 Mar;74(2):109-18
Walsh LP, Stocco DM. Effects of lindane on steroidogenesis and steroidogenic acute regulatory protein expression.Biol Reprod. 2000 Oct;63(4):1024-33.
Santos-Burgoa C, Downs TJ. Selecting high-priority hazardous chemicals for tri-national control: a maximum-utility method applied to Mexico.Int J Occup Environ Health. 2000 Jul-Sep;6(3):220-37.
Goldsmith DF. Linking environmental cancer with occupational epidemiology research: the role of the International Agency for Research on Cancer (IARC). J Environ Pathol Toxicol Oncol. 2000;19(1-2):171-5.

Mobile phones, magnetic fields.

Fews AP, Henshaw DL, Wilding RJ, Keitch PA. Corona ions from powerlines and increased exposure to pollutant aerosols. Int J Radiat Biol. 1999 Dec;75(12):1523-31.
Fews AP, Henshaw DL, Keitch PA, Close JJ, Wilding RJ. Increased exposure to pollutant aerosols under high voltage power lines. Int J Radiat Biol. 1999 Dec;75(12):1505-21
Purnell SJ, Allen JE, Oyedepo AC, Henshaw DL. Fetal dosimetry from natural alpha-particle emitters.
Radiat Res. 1999 Dec;152(6 Suppl):S133-6.
O'Donnell RG, Mitchell PI, Priest ND, Strange L, Fox A, Henshaw DL, Long SC. Variations in the concentration of plutonium, strontium-90 and total alpha-emitters in human teeth collected within the British Isles.
Sci Total Environ. 1997 Aug 18;201(3):235-43.
Henshaw DL. Re: Electromagnetic field exposure and lung cancer. Am J Epidemiol. 1997 Aug 15;146(4):366. No abstract available.
Verd S, Henshaw D, Sharma A. Childhood cancer in schools with a radioactive lightning rod.
Arch Dis Child. 1997 May;76(5):479-80. No abstract available
Henshaw DL. Chernobyl 10 years on. BMJ. 1996 Apr 27;312(7038):1052-3. No abstract available.
Henshaw DL, Ross AN, Fews AP, Preece AW. Enhanced deposition of radon daughter nuclei in the vicinity of power frequency electromagnetic fields. Int J Radiat Biol. 1996 Jan;69(1):25-38.
Cole J, Green MH, Bridges BA, Waugh AP, Beare DM, Henshaw D, Last R, Liu Y, Cortopassi G. Lack of evidence for an association between the frequency of mutants or translocations in circulating lymphocytes and exposure to radon gas in the home. Radiat Res. 1996 Jan;145(1):61-9.
Kefuss J, M'Diaye K, Bounias M, Vanpoucke J, Ecochard J. Biochemical effects of high intensity constant magnetic fields on worker honey bees.Bioelectromagnetics. 1999;20(2):117-22.
Daniells C, Duce I, Thomas D, Sewell P, Tattersall J, de Pomerai D. Transgenic nematodes as biomonitors of microwave-induced stress. Mutat Res. 1998 Mar 13;399(1):55-64
de Pomerai D. Heat-shock proteins as biomarkers of pollution.
Hum Exp Toxicol. 1996 Apr;15(4):279-85. Review. No abstract available.
de Pomerai D, Daniells C, David H, Allan J, Duce I, Mutwakil M, Thomas D, Sewell P, Tattersall J, Jones D, Candido P. Non-thermal heat-shock response to microwaves. Nature. 2000 May 25;405(6785):417-8. No abstract available.
Lebedeva NN, Sulimov AV, Sulimova OP, Korotkovskaya TI, Gailus T. Investigation of brain potentials in sleeping humans exposed to the electromagnetic field of mobile phones. Crit Rev Biomed Eng. 2001;29(1):125-33.
Maier R.[Is CNS activity modified by pulsed electromagnetic fields]?
Biomed Tech (Berl). 2001 Jan-Feb;46(1-2):18-23. German

Paredi P, Kharitonov SA, Hanazawa T, Barnes PJ. Local vasodilator response to mobile phones. Laryngoscope. 2001 Jan;111(1):159-62
Pereira C, Edwards M.Parotid nodular fasciitis in a mobile phone user. J Laryngol Otol. 2000 Nov;114(11):886-7.
Stang A, Anastassiou G, Ahrens W, Bromen K, Bornfeld N, Jockel KH The possible role of radiofrequency radiation in the development of uveal melanoma. Epidemiology. 2001 Jan;12(1):7-12
Vlassov V Health hazards of mobile phones. Do laptop computers also pose a risk? BMJ. 2000 Nov 4;321(7269):1156. No abstract available..
Chia SE, Chia HP, Tan JS. Health hazards of mobile phones. Prevalence of headache is increased among users in Singapore.BMJ. 2000 Nov 4;321(7269):1155-6. No abstract available.
French PW, Penny R, Laurence JA, McKenzie DR. Mobile phones, heat shock proteins and cancer.
Differentiation. 2001 Jun;67(4-5):93-7.

Radon

Eatough JP, Henshaw DL. Radon exposure and myeloid leukaemia. Int J Epidemiol. 1994 Apr;23(2):430-1. No abstract available.

Eatough JP, Henshaw DL. Radon and monocytic leukaemia in England. J Epidemiol Community Health. 1993 Dec;47(6):506-7.

Eatough JP, Henshaw DL. Radon and thoron associated dose to the basal layer of the skin.
Phys Med Biol. 1992 Apr;37(4):955-67.

Henshaw D. Radon and leukaemia. Leukemia. 1991 Sep;5(9):826-7. No abstract available.
Richardson RB, Eatough JP, Henshaw DL. Dose to red bone marrow from natural radon and thoron exposure.
Br J Radiol. 1991 Jul;64(763):608-24.

Bridges BA, Cole J, Arlett CF, Green MH, Waugh AP, Beare D, Henshaw DL, Last RD. Possible association between mutant frequency in peripheral lymphocytes and domestic radon concentrations. Lancet. 1991 May 18;337(8751):1187-9.

Eatough JP, Henshaw DL. Radon and prostate cancer. Lancet. 1990 May 26;335(8700):1292. No abstract available.

Henshaw DL, Eatough JP, Richardson RB. Radon as a causative factor in induction of myeloid leukaemia and other cancers. Lancet. 1990 Apr 28;335(8696):1008-12. Review.

Autism, ADHD, behaviourial difficulties

Vojdani A, Bazargan M, Vojdani E, Samadi J, Nourian AA, Eghbalieh N, Cooper EL. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease.
Clin Diagn Lab Immunol. 2004 May;11(3):515-24.
Megson MN. Is autism a G-alpha protein defect reversible with natural vitamin A?
Med Hypotheses. 2000 Jun;54(6):979-83.
Vojdani A, Pangborn JB, Vojdani E, Cooper EL. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism.
Int J Immunopathol Pharmacol. 2003 Sep-Dec;16(3):189-99.
Geier DA, Geier MR. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
Med Sci Monit. 2004 Mar 1 [Epub ahead of print]
Geier DA, Geier MR.An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
Pediatr Rehabil. 2003 Apr-Jun;6(2):97-102.
Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am J Prev Med. 2003 Aug;25(2):101-6.
Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism.
JAMA. 2003 Oct 1;290(13):1763-6.
Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication.
Exp Biol Med (Maywood). 2003 Jun;228(6):660-4.
Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH, Mortensen PB. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data.
Pediatrics. 2003 Sep;112(3 Pt 1):604-6.
Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in childhood vaccines.
Pediatrics. 2001 May;107(5):1147-54. Review.
Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California.
JAMA. 2001 Mar 7;285(9):1183-5.
Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: a novel form of mercury poisoning.
Med Hypotheses. 2001 Apr;56(4):462-71. Review.

Autism: International journal of Research

Walsh WJ, Isaacson HR, Rehman F, Hall A. Elevated blood copper/zinc ratios in assaultive young males.
Physiol Behav. 1997 Aug;62(2):327-9.
Singh VK, Lin SX, Newell E, Nelson C. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci. 2002 Jul-Aug;9(4):359-64.
Singh VK, Lin SX, Yang VC. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol. 1998 Oct;89(1):105-8.
Mills MJ, Savery D, Shattock PE. Rapid analysis of low levels of indolyl-3-acryloylglycine in human urine by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1998 Aug 7;712(1-2):51-8.
Minshew N. What are neuropeptides and neurotrophins and why are they imortant in autism?
J Autism Dev Disord. 2001 Oct;31(5):517. No abstract available.
Wong K. The search for autism's roots.
Nature. 2001 Jun 21;411(6840):882-4. No abstract available.
Gans DJ. Additional evidence for genetic component in autism.
J Autism Dev Disord. 1989 Mar;19(1):175-6. No abstract available.
Wolery M. Commentary: the environment as a source of variability: implications for research with individuals who have autism. J Autism Dev Disord. 2000 Oct;30(5):379-81. No abstract available.
Anderson RJ, Bendell DJ, Garnett I, Groundwater PW, Lough WJ, Mills MJ, Savery D, Shattock PE. Identification of indolyl-3-acryloylglycine in the urine of people with autism. J Pharm Pharmacol. 2002 Feb;54(2):295-8.
Alberti A, Pirrone P, Elia M, Waring RH, Romano C.
Sulphation deficit in "low-functioning" autistic children: a pilot study. Biol Psychiatry. 1999 Aug 1;46(3):420-4.
Linday LA. Oral famotidine: a potential treatment for children with autism. Med Hypotheses. 1997 May;48(5):381-6. Review.
Breakey J. The role of diet and behaviour in childhood. J Paediatr Child Health. 1997 Jun;33(3):190-4. Review.
Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, Burgess JR. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr. 1995 Oct;62(4):761-8.
Boris M, Mandel FS. Foods and additives are common causes of the attention deficit hyperactive disorder in children. Ann Allergy. 1994 May;72(5):462-8. Review.
Comings DE. Blood serotonin and tryptophan in Tourette syndrome. Am J Med Genet. 1990 Aug;36(4):418-30.

Ulcerative colitis, digestion etc.

Pitcher MC, Beatty ER, Harris RM, Waring RH, Cummings JH.
Sulfur metabolism in ulcerative colitis: investigation of detoxification enzymes in peripheral blood.
Dig Dis Sci. 1998 Sep;43(9):2080-5.

Davies MH, Ngong JM, Pean A, Vickers CR, Waring RH, Elias E.
Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis.
J Hepatol. 1995 May;22(5):551-60

Olomu AB, Vickers CR, Waring RH, Clements D, Babbs C, Warnes TW, Elias E
High incidence of poor sulfoxidation in patients with primary biliary cirrhosis.
N Engl J Med. 1988 Apr 28;318(17):1089-92.

Davies MH, Ngong JM, Yucesoy M, Acharya SK, Mills CO, Weaver JB, Waring RH, Elias E.
The adverse influence of pregnancy upon sulphation: a clue to the pathogenesis of intrahepatic cholestasis of pregnancy?

Davies MH, Klovrza L, Waring RH, Elias E. Plasma cysteine and sulphate levels in patients with cirrhosis of the liver.

Watson RG, Olomu A, Clements D, Waring RH, Mitchell S, Elias E.
A proposed mechanism for chlorpromazine jaundice--defective hepatic sulphoxidation combined with rapid hydroxylation.
J Hepatol. 1988 Aug;7(1):72-8. Clin Sci (Lond). 1994 Sep;87(3):357-62.

HIV

Folkers K, Hanioka T, Xia LJ, McRee JT Jr, Langsjoen P. Coenzyme Q10 increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the AIDS related complex. Biochem Biophys Res Commun. 1991 Apr 30;176(2):786-91.

Micke P, Beeh KM, Buhl R. Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients.Eur J Nutr. 2002 Feb;41(1):12-8.

Harakeh S, Jariwalla RJ, Pauling L. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7245-9.

Huengsberg M, Waring R, Moffitt D, Round R, Winer J, Gompels M, Shahmanesh M. Serum cysteine levels in HIV infection. AIDS. 1998 Jul 9;12(10):1245. No abstract available

James JS. NAC: first controlled trial, positive results. AIDS Treat News. 1996 Jul 5;(no 250):1-3. Review. No abstract available.
Batterham M, Gold J, Naidoo D, Lux O, Sadler S, Bridle S, Ewing M, Oliver C. A preliminary open label dose comparison using an antioxidant regimen to determine the effect on viral load and oxidative stress in men with HIV/AIDS. Eur J Clin Nutr. 2001 Feb;55(2):107-14.

Sung JH, Shin SA, Park HK, Montelaro RC, Chong YH. Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells. J Neurovirol. 2001 Oct;7(5):454-65.

Mollace V, Nottet HS, Clayette P, Turco MC, Muscoli C, Salvemini D, Perno CF. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 2001 Jul;24(7):411-6. Review.

Yamauchi A, Tsuyuki S, Inamoto T, Yamaoka Y .Liver immunity and glutathione. Antioxid Redox Signal. 1999 Summer;1(2):245-53. Review.

Bounous G, Baruchel S, Falutz J, Gold P. Whey proteins as a food supplement in HIV-seropositive individuals.
Clin Invest Med. 1993 Jun;16(3):204-9.

Bounous G, Gold P. The biological activity of undenatured dietary whey proteins: role of glutathione.
Clin Invest Med. 1991 Aug;14(4):296-309

Muller F, Svardal AM, Nordoy I, Berge RK, Aukrust P, Froland SS. Virological and immunological effects of antioxidant treatment in patients with HIV infection. Eur J Clin Invest. 2000 Oct;30(10):905-14.

Reid G. Specific toxins destabilize virus inhibitors (e.g. AIDS viruses). Med Hypotheses. 2000 Jun;54(6):917-8

Sprietsma JE. Cysteine, glutathione (GSH) and zinc and copper ions together are effective, natural, intracellular inhibitors of (AIDS) viruses. Med Hypotheses. 1999 Jun;52(6):529-38. Review

.Exner R, Wessner B, Manhart N, Roth E. Therapeutic potential of glutathione. Wien Klin Wochenschr. 2000 Jul 28;112(14):610-6. Review.

Migraine

Alam Z, Coombes N, Waring RH, Williams AC, Steventon GB. Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J Neurol Sci. 1998;156(1):102-6.

Alam Z, Coombes N, Waring RH, Williams AC, Steventon GB. Platelet sulphotransferase activity, plasma sulphate levels and sulphation capacity in patients with migraine and tension headache. Cephalalgia. 1997 Nov;17(7):761-4.

Rheumatoid arthritis

Grennan DM, Knudson JM, Dunckley J, MacKinnon MJ, Myers DB, Palmer DG. Serum copper and zinc in rheumatoid arthritis and osteoarthritis. N Z Med J. 1980 Jan 23;91(652):47-50.

Aiginger P, Kolarz G, Willvonseder R. Copper in ankylosing spondylitis and rheumatoid arthritis. Scand J Rheumatol. 1978;7(2):75-8.

Weber CE. Copper response to rheumatoid arthritis. Med Hypotheses. 1984 Dec;15(4):333-48. Review.

Turner S, Cherry N. Rheumatoid arthritis in workers exposed to silica in the pottery industry.
Occup Environ Med. 2000 Jul;57(7):443-7.

Bradley H, Gough A, Sokhi RS, Hassell A, Waring R, Emery P. Sulfate metabolism is abnormal in patients with rheumatoid arthritis. Confirmation by in vivo biochemical findings. J Rheumatol. 1994 Jul;21(7):1192-6

Murphy EA, Madhok R, Capell HA, Waring R, Hunter JA. Sulphoxidation status in rheumatoid arthritis. Ann Rheum Dis. 1993 Feb;52(2):168. No abstract available.

Emery P, Bradley H, Arthur V, Tunn E, Waring R. Genetic factors influencing the outcome of early arthritis--the role of sulphoxidation status.Br J Rheumatol. 1992 Jul;31(7):449-51

Emery P, Bradley H, Gough A, Arthur V, Jubb R, Waring R. Increased prevalence of poor sulphoxidation in patients with rheumatoid arthritis: effect of changes in the acute phase response and second line drug treatment. Ann Rheum Dis. 1992 Mar;51(3):318-20.

Bradley H, Waring RH, Emery P Reduced thiol methyl transferase activity in red blood cell membranes from patients with rheumatoid arthritis. J Rheumatol. 1991 Dec;18(12):1787-9.

Kjeldsen-Kragh J, Sumar N, Bodman-Smith K, Brostoff J. Changes in glycosylation of IgG during fasting in patients with rheumatoid arthritis. Br J Rheumatol. 1996 Feb;35(2):117-9.

Chinese Herbs/ Allergy

Garrett MH, Hooper MA, Hooper BM, Rayment PR, Abramson MJ. Increased risk of allergy in children due to formaldehyde exposure in homes. Allergy. 1999 Apr;54(4):330-7.

Garrett MH, Hooper BM, Hooper MA. Indoor environmental factors associated with house-dust-mite allergen (Der p 1) levels in south-eastern Australian houses. Allergy. 1998 Nov;53(11):1060-5.

Garrett MH, Hooper MA, Hooper BM, Abramson MJ. Respiratory symptoms in children and indoor exposure to nitrogen dioxide and gas stoves. Am J Respir Crit Care Med. 1998 Sep;158(3):891-5.
Radcliffe MJ, Ashurst P, Brostoff J. Unexplained illness: the mind versus the environment. J R Soc Med. 1995 Dec;88(12):678-9. Review.
Latchman Y, Banerjee P, Poulter LW, Rustin M, Brostoff J. Association of immunological changes with clinical efficacy in atopic eczema patients treated with traditional Chinese herbal therapy (Zemaphyte). Int Arch Allergy Immunol. 1996 Mar;109(3):243-9.

Loza C, Brostoff J. Peanut allergy. Clin Exp Allergy. 1995 Jun;25(6):493-502. Review. No abstract available.

Latchman Y, Bungy GA, Atherton DJ, Rustin MH, Brostoff J. Efficacy of traditional Chinese herbal therapy in vitro. A model system for atopic eczema: inhibition of CD23 expression on blood monocytes. Br J Dermatol. 1995 Apr;132(4):592-8

Sheehan MP, Stevens H, Ostlere LS, Atherton DJ, Brostoff J, Rustin MH. Follow-up of adult patients with atopic eczema treated with Chinese herbal therapy for 1 year. Clin Exp Dermatol. 1995 Mar;20(2):136-40.

Anthony HM, Birtwistle S, Brostoff J, Eaton KK, Hearn G, Maberly DJ, Mansfield JR, Radcliffe M, Tettenborn M. Food intolerance. Lancet. 1994 Jul 9;344(8915):136-7; discussion 137-8. No abstract available.

Motor Neurone Disease, Alzheimers, Amyotrophic Lateral sclerosis, neurodegeneration etc.

Morris HR, Al-Sarraj S, Schwab C, Gwinn-Hardy K, Perez-Tur J, Wood NW, Hardy J, Lees AJ, McGeer PL, Daniel SE, Steele JC.
A clinical and pathological study of motor neurone disease on Guam. Brain. 2001 Nov;124(Pt 11):2215-22.
Summers WK. Bismuth Toxicity Masquerading as Alzheimer's Dementia. J Alzheimers Dis. 1998 Mar;1(1):57-59
Steventon GB, Waring RH, Williams AC. Pesticide toxicity and motor neuron disease. J Neurol Neurosurg Psychiatry. 1990 Jul;53(7):621-2. No abstract available.
Pall HS, Williams AC, Waring R, Elias E. Motoneurone disease as manifestation of pesticide toxicity. Lancet. 1987 Sep 19;2(8560):685. No abstract available.
Steventon GB, Heafield MT, Sturman S, Waring RH, Williams AC. Xenobiotic metabolism in Alzheimer's disease. Neurology. 1990 Jul;40(7):1095-8.
White AR, Huang X, Jobling MF, Barrow CJ, Beyreuther K, Masters CL, Bush AI, Cappai R. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J Neurochem. 2001 Mar;76(5):1509-20.
Pean A, Steventon GB, Waring RH, Foster H, Sturman S, Williams AC.
Pathways of cysteine metabolism in MND/ALS. J Neurol Sci. 1994 Jul;124 Suppl:59-61
Pean AR, Parsons RB, Waring RH, Williams AC, Ramsden DB..
Toxicity of sulphur-containing compounds to neuronal cell lines. J Neurol Sci. 1995 May;129 Suppl:107-8
Steventon GB, Waring RH, Heafield MT, Sturman SG, Williams AC. Cystine, sulfate, and ALS. Neurology. 1991 Nov;41(11):1851-2. No abstract available
Williams AC, Steventon GB, Sturman S, Waring RH. Hereditary variation of liver enzymes involved with detoxification and neurodegenerative disease. J Inherit Metab Dis. 1991;14(4):431-5. Review.
Heafield MT, Fearn S, Steventon GB, Waring RH, Williams AC, Sturman SG.
Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett. 1990 Mar 2;110(1-2):216-20.
Waring RH, Steventon GB, Sturman SG, Heafield MT, Smith MC, Williams AC
S-methylation in motorneuron disease and Parkinson's disease. Lancet. 1989 Aug 12;2(8659):356-7.
Steventon G, Williams AC, Waring RH, Pall HS, Adams D. Xenobiotic metabolism in motor neuron disease. Lancet. 1988 Sep 17;2(8612):644-7.
Stroombergen MC, Waring RH. Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum Exp Toxicol. 1999 Mar;18(3):141-5.

Guam/ALS etc

Poorkaj P, Tsuang D, Wijsman E, Steinbart E, Garruto RM, Craig UK, Chapman NH, Anderson L, Bird TD, Plato CC, Perl DP, Weiderholt W, Galasko D, Schellenberg GD. TAU as a Susceptibility Gene for Amyotropic Lateral Sclerosis-Parkinsonism Dementia Complex of Guam. Arch Neurol. 2001 Nov;58(11):1871-1878.
Schmidt ML, Zhukareva V, Perl DP, Sheridan SK, Schuck T, Lee VM, Trojanowski JQ. Spinal cord neurofibrillary pathology in Alzheimer disease and Guam Parkinsonism-dementia complex. J Neuropathol Exp Neurol. 2001 Nov;60(11):1075-86.
Yamazaki M, Makifuchi T, Chen KM, Mori O, Katayama Y, Takahashi H, Oyanagi K. Progressive supranuclear palsy on Guam. Acta Neuropathol (Berl). 2001 Nov;102(5):510-4.
Morris HR, Al-Sarraj S, Schwab C, Gwinn-Hardy K, Perez-Tur J, Wood NW, Hardy J, Lees AJ, McGeer PL, Daniel SE, Steele JC. A clinical and pathological study of motor neurone disease on Guam. Brain. 2001 Nov;124(Pt 11):2215-2222.Behan PO, Bakheit AM.. Association of amyotrophic lateral sclerosis, Hoigne's syndrome and residence in Guam. J Neurol Neurosurg Psychiatry. 1991 Jan;54(1):90-1. No abstract available

Systemic Lupus

Gordon C, Bradley H, Waring RH, Emery Abnormal sulphur oxidation in systemic lupus erythematosus. Lancet. 1992 Jan 4;339(8784):25-6.

Schizophrenia

Pfeiffer CC. Schizophrenia and wheat gluten enteropathy. Biol Psychiatry. 1984 Mar;19(3):279-80. No abstract available
Fernandez-Novoa L, Cacabelos R. Histamine function in brain disorders.
Behav Brain Res. 2001 Oct 15;124(2):213-233.
Johnson S. Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease?
Med Hypotheses. 2001 May;56(5):641-5.
Azorin JM, Samuelian-Massat C, Jeanningros R, Widmer J, Tissot R. [Erythrocyte membrane transports of monoamine precursor amino acids in schizophrenia].
Encephale. 1991 Mar-Apr;17(2):83-6. French.
Krischer K, Pfeiffer CC. Biochemical relationship between kryptopyrrole (mauve factor and trans-3-methyl-2-hexenoic acid (schizophrenia odor).
Res Commun Chem Pathol Pharmacol. 1973 Jan;5(1):9-15. No abstract available.
Pfeiffer CC, Smyrl EG, Iliev V. Extreme basophil counts and blood histamine levels in schizophrenic outpatients as compared to normals.
Res Commun Chem Pathol Pharmacol. 1972 Jul;4(1):51-9. No abstract available
Pfeiffer CC. Extra nutrients and mental illness. Biol Psychiatry. 1981 Sep;16(9):797-9. No abstract available.
Goldstein L, Pfeiffer CC. Effects of single oral doses of trace elements on the quantitated EEG of normal subjects and chronic schizophrenics [proceedings] Psychopharmacol Bull. 1978 Jul;14(3):55-7. No abstract available.
Pfeiffer CC. Blood histamine, basophil counts and trace elements in the schizophrenias. Rev Can Biol. 1972;31:Suppl:73-6. No abstract available.

Pfeiffer CC, Iliev V, De Gara M, Smyrl EG, Cawley JC. Blood histamine levels, basophil counts, and trace metals in the schizophrenias.
Psychopharmacol Bull. 1971 Jul;7(3):37. No abstract available.

Pfeiffer CC, Iliev V, Jenney EH, Cawley J. A longitudinal study of trace metal therapy in the copper loaded schizophrenic patient.
Psychopharmacol Bull. 1971 Jul;7(3):33-4. No abstract available.

Herran A, Garcia-Unzueta MT, Fernandez-Gonzalez MD, Vazquez-Barquero JL, Alvarez C, Amado JA. Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics. Psychiatry Res. 2000 Apr 24;94(1):51-8.
Lohr JB, Browning JA. Free radical involvement in neuropsychiatric illnesses. Psychopharmacol Bull. 1995;31(1):159-65. Review.
Vitorovic S, Lieina M .Wilson's disease and mental disturbances. Can J Psychiatry. 1996 Mar;41(2):132-3. No abstract available.
Vieira RM, da Silva IJ, Azevedo M, Manso CF. [An analysis of plasma histaminase in schizophrenic patients and its relationship to clinical parameters]. Acta Med Port. 1995 May;8(5):289-97. Portuguese.

Homeopathy

Crocnan DO, Greabu M, Olinescu R. Stimulatory effect of some plant extracts used in homeopathy on the phagocytosis induced chemiluminescence of polymorphonuclear leukocytes. Rocz Akad Med Bialymst. 2000;45:246-54.

Smith CA. Homoeopathy for induction of labour (Cochrane Review). Cochrane Database Syst Rev. 2001;4:CD003399.

Sudden infant death Syndrome

Kelley J, Allsopp D, Hawksworth DL. Sudden infant death syndrome (SIDS) and the toxic gas hypothesis: microbiological studies of cot mattresses. Hum Exp Toxicol. 1992 Sep;11(5):347-55.

Warnock DW, Delves HT, Campell CK, Croudace IW, Davey KG, Johnson EM, Sieniawska C Toxic gas generation from plastic mattresses and sudden infant death syndrome. Lancet. 1995 Dec 9;346(8989):1516-20.

Kurup VP, Xia JQ, Shen HD, Rickaby DA, Henderson JD Jr, Fink JN, Chou H, Kelly KJ, Dawson CA. Alkaline serine proteinase from Aspergillus fumigatus has synergistic effects on Asp-f-2-induced immune response in mice. Int Arch Allergy Immunol. 2002 Oct;129(2):129-37.

Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 2002 Nov;110(5):685-92.

Nieminen SM, Karki R, Auriola S, Toivola M, Laatsch H, Laatikainen R, Hyvarinen A, Von Wright A. Isolation and identification of Aspergillus fumigatus mycotoxins on growth medium and some building materials. Appl Environ Microbiol. 2002 Oct;68(10):4871-5.

Kamei K, Watanabe A, Nishimura K, Miyaji M. Cytotoxicity of Aspergillus fumigatus culture filtrate against macrophages. Nippon Ishinkin Gakkai Zasshi. 2002;43(1):37-41.

Tappin D, Brooke H, Ecob R, Gibson A. Used infant mattresses and sudden infant death syndrome in Scotland: case-control study. BMJ. 2002 Nov 2;325(7371):1007.

Colditz PB, Joy GJ, Dunster KR. Rebreathing potential of infant mattresses and bedcovers.
J Paediatr Child Health. 2002 Apr;38(2):192-5.

Coates EL. Olfactory CO(2) chemoreceptors. Respir Physiol. 2001 Dec;129(1-2):219-29. Review.

Patel AL, Harris K, Thach BT. Inspired CO(2) and O(2) in sleeping infants rebreathing from bedding: relevance for sudden infant death syndrome. J Appl Physiol. 2001 Dec;91(6):2537-45.

Richardson BA. Cot death and cot mattresses. N Z Med J. 1996 Jan 26;109(1014):19. No abstract available.

Richardson BA. Cot death and cot mattresses.N Z Med J. 1995 Sep 8;108(1007):370. No abstract available.

Richardson BA. Cot mattresses and sudden infant death syndrome. Lancet. 1995 Apr 22;345(8956):1045. No abstract available.

Richardson BA. Cot mattresses and the sudden infant death syndrome. BMJ. 1995 Apr 22;310(6986):1071. No abstract available.

Richardson BA. Sudden infant death syndrome: a possible primary cause. J Forensic Sci Soc. 1994 Jul-Sep;34(3):199-204.

Richardson BA Mattresses and cot death. Lancet. 1991 May 25;337(8752):1285. No abstract available.

Richardson BA. Cot mattress biodeterioration and SIDS. Lancet. 1990 Mar 17;335(8690):670. No abstract available.

Mitchell EA, Scragg L, Clements M. Cot mattresses and sudden infant death syndrome.
Lancet. 1995 Apr 22;345(8956):1045-6. No abstract available.

Howatson AG, Patrick WJ, Fell GS, Lyon TD, Gibson AA. Cot mattresses and sudden infant death syndrome.
Lancet. 1995 Apr 22;345(8956):1044-5. No abstract available.

Bell SA, Cole M. Cot mattresses and sudden infant death syndrome.
Lancet. 1995 Apr 22;345(8956):1046. No abstract available.

Kemp JS. Sudden infant death syndrome: the role of bedding revisited.
J Pediatr. 1996 Dec;129(6):946-7. No abstract available.

Mitchell EA. Cot death and cot mattresses. N Z Med J. 1995 Oct 27;108(1010):443-4. No abstract available.

Seifert P. Letter: Sudden infant death syndrome. Med J Aust. 1975 Nov 22;2(21):809. No abstract available.

No authors listed] Bedding and sleeping position in the sudden infant death syndrome.
BMJ. 1990 Sep 8;301(6750):492-4. No abstract available.

Kemp JS, Thach BT. The risk of sudden infant death. N Engl J Med. 1994 Jan 6;330(1):63; discussion 64. No abstract available.

Draper G, Holland W. Case-control study of sudden infant death syndrome in Scotland. Multiple statistical comparisons used are confusing.
BMJ. 1997 Sep 27;315(7111):812-3. No abstract available.

Jackson S. Sudden infant death syndrome. Part 2. Possible causes of SIDS. Midwives Chron. 1992 Sep;105(1256):274-8. No abstract available.

Hassall IB, Tonkin SL. A hypothesis about cot death. N Z Med J. 1989 Sep 13;102(875):480. No abstract available.

Fleming P, Berry J, Gilbert R, Rudd P. Bedding and sleeping position in the sudden infant death syndrome.
BMJ. 1990 Oct 13;301(6756):871-2. No abstract available.

Gotestam KG. [Sudden infant death in Norway--does bedding play any role?] Tidsskr Nor Laegeforen. 1991 Nov 30;111(29):3544-5. Review. Norwegian.

Taylor BJ, Campbell AJ, Bolton DP. Sudden infant death syndrome J Paediatr Child Health. 1994 Feb;30(1):83-4. No abstract available.
Ponsonby AL, Dwyer T, Couper D, Cochrane J. Association between use of a quilt and sudden infant death syndrome: case-control study.
BMJ. 1998 Jan 17;316(7126):195-6. No abstract available.

Beal S. Sudden infant death syndrome related to sleeping position and bedding.
Med J Aust. 1991 Oct 21;155(8):507-8. Review. No abstract available.

Fluoride

Colquhoun J. New evidence on fluoridation. N Z Dent J. 1997 Dec;93(414):132-3. No abstract available.
Colquhoun J. Why I changed my mind about water fluoridation. Perspect Biol Med. 1997 Autumn;41(1):29-44. No abstract available.
Diesendorf M, Colquhoun J, Spittle BJ, Everingham DN, Clutterbuck FW. New evidence on fluoridation. Aust N Z J Public Health. 1997 Apr;21(2):187-90. Review.